You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Is the incidence of paediatric inflammatory bowel disease still increasing?
  1. James John Ashton1,2,
  2. Mick Cullen1,
  3. Nadeem A Afzal1,
  4. Tracy Coelho1,
  5. Akshay Batra1,
  6. R Mark Beattie1
  1. 1 Department of Paediatric Gastroenterology, Southampton Children’s Hospital, Southampton, UK
  2. 2 Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK
  1. Correspondence to Dr R Mark Beattie, Department of Paediatric Gastroenterology, Southampton Children’s Hospital, Southampton SO16 6YD, UK ; mark.beattie{at}uhs.nhs.uk

https://doi.org/10.1136/archdischild-2018-315038

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    There has been an increase in the incidence of paediatric inflammatory bowel disease (PIBD) over the last 20 years.1 2 We have previously published data from Wessex, England, reporting an incidence of 9.37/100 000/year (2008–2012), which significantly increased from 5.2/100 000/year in 1998–1999, 6.39/100 000/year in 2002–2006, and 7.82/100 000/year in 2003–2008.1 2 We now report the most recent disease incidence figures for Wessex, England (1 January 2013 to 31 December 2017) and analyse them with previously published Wessex data (1 January 2002 to 21 December 2012) demonstrating the most contemporary incidence and the trend over 16 years. The ‘Wessex’ population was estimated from the Office for National Statistics using defined postcodes, based on the contemporary referral area.1 3 Statistical analyses of the data were conducted …

    View Full Text

    Footnotes

    • Contributors JJA and RMB conceived the study. JJA and MC collected the data. JJA analysed the data with help from all the authors. JJA and RMB wrote the manuscript with help from all the authors.

    • Funding JJA is funded by an Action Medical Research, Research Training Fellowship.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.